What Does Dexamethasone Do and How Does It Work?

Dexamethasone is a synthetic corticosteroid that suppresses inflammation and tames an overactive immune system. First synthesized in 1958 as a modified version of cortisone, it remains one of the most widely prescribed steroids in the world, used in settings ranging from intensive care units to mountaineering expeditions. What makes it unusual among steroids is its potency and its lack of a significant salt-retaining effect, which means it can deliver powerful anti-inflammatory action without pushing the body to hold onto sodium and water the way some of its relatives do.

How Dexamethasone Works Inside Cells

Dexamethasone’s primary mechanism is often called “genomic” because it changes which genes get switched on or off. The drug passes through cell membranes and binds to a receptor called the glucocorticoid receptor, which sits in the cytoplasm. Once dexamethasone latches on, this receptor migrates into the nucleus, where it can directly influence gene activity. One of its most important targets is a protein complex called NF-κB, which acts as a master switch for many inflammatory genes. Research has shown that the activated glucocorticoid receptor interferes with the ability of NF-κB’s p65 subunit to turn on inflammatory gene transcription, effectively muting the signal before it can produce inflammatory molecules.¹

This gene-silencing effect is not instantaneous. Because it requires the drug to enter the nucleus, bind DNA-regulating machinery, and alter protein production, the full genomic response takes hours to develop. That delay matters clinically: when a doctor gives dexamethasone for a swollen brain or inflamed lung, the peak benefit does not arrive immediately.

Dexamethasone also has faster, “non-genomic” effects that unfold within minutes. These involve interactions with cell membrane receptors that can activate signaling cascades, including pathways involving MAP kinases and calcium-dependent signaling.² These rapid effects are less well understood than the genomic pathway, but they help explain why some benefits of dexamethasone seem to appear faster than the gene-regulation timeline alone would predict.

Why Dexamethasone Is So Much Stronger Than Other Steroids

Not all corticosteroids are created equal. Dexamethasone stands out for an exceptionally high potency relative to the body’s own cortisol (hydrocortisone). In a study measuring how strongly different steroids suppress the pituitary-adrenal axis over time, dexamethasone was roughly 17 times as potent as hydrocortisone when adjusted for differences in how fast each drug clears the bloodstream. At the 8-hour mark after a dose, the gap widened even further, with dexamethasone registering about 52 times the potency of hydrocortisone, compared to just 3 times for prednisone.³ This means that a small dose of dexamethasone can accomplish what would require a much larger dose of prednisone or hydrocortisone.

Its biological half-life, the time for its effect on the body to drop by half, is also considerably longer than hydrocortisone’s. The drug itself is cleared from the blood with a half-life of roughly 4 to 9 hours, but because of how deeply it alters gene expression, its biological effects linger well beyond its presence in the bloodstream.⁴ This long tail of activity is why dexamethasone can be dosed once a day in many situations, whereas shorter-acting steroids need multiple doses.

What Dexamethasone Does to White Blood Cells

One of the more counterintuitive things dexamethasone does is raise your white blood cell count while simultaneously suppressing inflammation. If you get blood work done while taking dexamethasone, you may see a high neutrophil count that looks alarming. But this is a well-understood pharmacological effect, not a sign of infection.

Dexamethasone increases the number of circulating neutrophils through several overlapping mechanisms. Research tracking labeled neutrophils found that the biggest contributor, accounting for about 61% of the rise, was mobilization from a “marginated pool” of neutrophils that normally stick to blood vessel walls. Another 29% came from neutrophils simply lasting longer in the circulation, with their half-life nearly doubling from about 5 hours to roughly 9.5 hours. The remaining 10% or so came from faster release of newly made neutrophils from bone marrow.⁵

The drug’s relationship with different types of white blood cells is surprisingly selective. It delays programmed cell death in neutrophils by stabilizing a survival protein called Mcl-1L, keeping them alive longer in circulation. But it does exactly the opposite to eosinophils, a type of white blood cell involved in allergic inflammation, by accelerating the loss of that same survival protein and hastening their death.⁶ This selective killing of eosinophils is part of why corticosteroids are so effective for asthma and allergic conditions, where eosinophils drive much of the tissue damage.

The COVID-19 Breakthrough

Dexamethasone became a household name in 2020 when a large UK trial called RECOVERY showed it could save lives in hospitalized COVID-19 patients. Among patients who were on mechanical ventilators, dexamethasone reduced the death rate from about 41% to about 29%, a relative reduction of roughly a third. For patients receiving supplemental oxygen without a ventilator, the benefit was smaller but still meaningful, with deaths falling from about 26% to about 23%.⁷

The finding had an important caveat that shaped how doctors use the drug. In patients who were not sick enough to need any respiratory support, dexamethasone showed no benefit and even hinted at possible harm, with a higher death rate in the treatment group, though that difference was not statistically definitive.⁷ This makes biological sense. In severe COVID-19, an overblown inflammatory response damages the lungs more than the virus itself does. Dexamethasone dials down that destructive immune overreaction. But in early or mild disease, the immune response is still doing useful work fighting the virus, and suppressing it can backfire. The timing of steroid use in infectious disease is one of the trickiest judgment calls in medicine.

Reducing Brain Swelling

Long before COVID-19, dexamethasone was established as a go-to drug in neurosurgery for managing swelling around brain tumors. It was first used for this purpose in the early 1960s, and it has been a standard treatment for more than 60 years.⁸ The swelling around a brain tumor, called peritumoral edema, happens because the tumor disrupts the blood-brain barrier, letting fluid leak into surrounding brain tissue.

Dexamethasone works against this leak by tightening up the junctions between cells in blood vessel walls. Research has identified several tight-junction proteins, including occludin, claudin-5, and ZO-1, whose expression and arrangement in brain blood vessels are restored by glucocorticoid treatment.⁹ By shoring up these molecular seals, dexamethasone reduces the leakiness of vessels and allows the excess fluid to be gradually reabsorbed. The clinical effect can be dramatic: patients with disabling headaches, weakness, or confusion from brain swelling sometimes improve visibly within a day or two of starting the drug.

Helping Premature Babies Breathe

When a baby is at risk of being born too early, doctors often give the mother a course of corticosteroids to speed up fetal lung development. Corticosteroids promote the production of surfactant, a mixture of proteins and fats that coats the inside of the lungs and prevents the tiny air sacs from collapsing with each breath.¹⁰ Premature infants who have not yet made enough surfactant develop respiratory distress syndrome, which can be life-threatening.

Both dexamethasone and betamethasone are used for this purpose, and a Cochrane review comparing the two found some differences. Dexamethasone was associated with a lower incidence of intraventricular hemorrhage, a type of brain bleeding common in premature infants, compared to betamethasone.¹⁰ The route of administration matters too: one trial found that giving dexamethasone by mouth rather than by injection was linked to a substantially higher rate of neonatal sepsis, suggesting that the injectable route is preferred for safety.¹⁰

Chemotherapy Support and the Hiccup Problem

If you have ever undergone chemotherapy, there is a good chance you received dexamethasone. It is a cornerstone of antiemetic regimens, the drug combinations used to prevent the nausea and vomiting that many chemotherapy agents provoke. The reasons it works for nausea are not entirely clear but likely involve both its anti-inflammatory action in the gut and its effects on brain centers that trigger vomiting.

Dexamethasone brings a peculiar side effect in this setting: hiccups. A randomized crossover trial in cancer patients found that hiccups occurred in about 85% of patients during dexamethasone-based antiemetic treatment, compared with about 63% of patients receiving methylprednisolone instead. The intensity was also significantly worse with dexamethasone. When patients were switched from dexamethasone to methylprednisolone, their hiccup scores dropped sharply, and when they were switched in the other direction, hiccup intensity climbed.¹¹ This is rarely dangerous, but persistent hiccups for days after chemotherapy can be exhausting and distressing. The trial demonstrated that switching to methylprednisolone offered comparable nausea control with much less hiccupping.

Dexamethasone as a Diagnostic Tool

Dexamethasone is not always given as a treatment. Endocrinologists also use it as a test. The dexamethasone suppression test exploits the drug’s potent ability to shut down the body’s own cortisol production through feedback on the pituitary gland. In a healthy person, taking a dose of dexamethasone at night causes morning cortisol levels to plummet. In someone with Cushing’s syndrome, where cortisol stays abnormally high, the response to dexamethasone helps pinpoint the cause.

Different doses are used to distinguish between different sources of excess cortisol. A low dose screens for Cushing’s syndrome in general. Higher doses help sort out whether the problem is a pituitary tumor, an adrenal tumor, or an ectopic source of hormone production. Research on very high-dose versions of the test has shown that while cortisol suppression can be diagnostically useful, the corresponding suppression of ACTH (the pituitary hormone that drives cortisol production) is often less clear-cut and does not add much diagnostic value on its own.¹²

Eye Conditions and Implantable Dexamethasone

Dexamethasone also works in the eye, where it is used to treat conditions like macular edema, the swelling of the central retina that can blur or destroy vision. A sustained-release implant, roughly the size of a grain of rice, can be injected directly into the vitreous cavity of the eye. This approach delivers the drug right where it is needed and avoids most of the systemic side effects associated with oral steroids.

A prospective study of these implants found that about 88% of treated eyes gained at least three lines of visual acuity within two months. However, the effect is not permanent. On average, anatomical signs of the edema returning appeared around four months after injection, with vision starting to decline roughly two weeks after the structural changes reappeared.¹³ This means patients typically need repeat injections several times a year, which is one of the practical downsides of the treatment.

Altitude Sickness Prevention

Climbers and trekkers heading to high altitude sometimes carry dexamethasone tablets as both a preventive measure and an emergency treatment for acute mountain sickness and its dangerous relative, high-altitude cerebral edema. A systematic review and meta-analysis found that oral dexamethasone was effective in reducing the incidence of acute mountain sickness, with the treated group being about six times less likely to develop it compared to placebo. The effect appeared to be related to both the altitude reached and the dose used.¹⁴

In wilderness medicine, dexamethasone is considered a rescue drug for severe altitude illness. If someone develops cerebral edema at high altitude, dexamethasone can buy time while the person is evacuated to a lower elevation. It does not acclimatize you to altitude and should not be thought of as a substitute for a proper ascent schedule, but it can be lifesaving when things go wrong far from a hospital.

Side Effects and the Risks of Long-Term Use

The same potency that makes dexamethasone effective also makes its side effects significant, especially with prolonged use. Short courses of a few days generally produce manageable problems: insomnia, mood changes, elevated blood sugar, and increased appetite are the most common complaints. The sleep disruption in particular is well recognized and is thought to involve disruption of natural sleep-wake cycles and modification of neuroinhibitory brain pathways.¹⁵ Some patients taking dexamethasone describe a wired, restless feeling that makes sleep nearly impossible, even when they are exhausted.

Long-term use carries all the familiar risks of chronic corticosteroid therapy: thinning bones, muscle weakness, skin fragility, weight gain concentrated in the face and trunk, elevated blood pressure, increased susceptibility to infections, and cataracts. Because dexamethasone is so potent, it is also very effective at shutting down the body’s natural cortisol production. After weeks of use, the adrenal glands become sluggish. Stopping abruptly can precipitate adrenal crisis, a dangerous drop in cortisol that causes weakness, low blood pressure, and in severe cases, circulatory collapse. This is why doctors taper the dose gradually rather than discontinuing it all at once.

Why Some People Do Not Respond Well

Not everyone responds equally to dexamethasone. Corticosteroid resistance is a recognized phenomenon, particularly in conditions like severe asthma, inflammatory bowel disease, and some autoimmune disorders. Part of the explanation may lie in the glucocorticoid receptor itself, which exists in two forms: an alpha isoform that mediates the drug’s anti-inflammatory effects, and a beta isoform that appears to act as a natural brake on glucocorticoid signaling. Studies measuring the levels of these isoforms across human tissues found that the alpha form was dominant everywhere, with the highest levels in the brain and skeletal muscle. The beta form was present in much smaller amounts, with the highest concentrations in eosinophils and immune cells. While the beta isoform’s protein was not detectable in any tissue studied, its messenger RNA was measurable, and the ratio of alpha to beta may influence how sensitive different tissues are to steroid treatment.¹⁶

Drug interactions also affect how well dexamethasone works. The drug is broken down primarily by the liver enzyme CYP3A4, and less than 10% leaves the body unchanged in urine.⁴ Any medication that strongly induces or inhibits CYP3A4 can alter dexamethasone levels in the blood. Drugs like rifampin, phenytoin, and certain antiretrovirals can speed up dexamethasone’s breakdown and reduce its effectiveness. Conversely, potent CYP3A4 inhibitors like ketoconazole can cause dexamethasone levels to build up higher than expected. Body composition matters as well: studies in children and adolescents with obesity found substantial variability in how quickly dexamethasone was cleared, which has practical implications for dosing in that population.⁴

The Upstream Anti-Inflammatory Step

Beyond shutting down NF-κB, dexamethasone also blocks inflammation at an earlier chemical step by reducing the supply of raw materials that the body uses to make inflammatory signaling molecules like prostaglandins and leukotrienes. It does this partly through a protein called annexin 1 (also known as lipocortin 1), which inhibits an enzyme called phospholipase A2. This enzyme normally frees arachidonic acid from cell membranes, and arachidonic acid is the starting material for a whole family of inflammatory compounds. By boosting annexin 1 production, dexamethasone chokes off the supply chain before it even gets started.¹⁷ This mechanism is distinct from how common painkillers like ibuprofen work. Those drugs block the enzymes that convert arachidonic acid into prostaglandins, but by the time they act, arachidonic acid is already loose. Dexamethasone operates one step upstream, which is part of why its anti-inflammatory reach is broader than that of standard anti-inflammatory painkillers.

1
PubMed. Glucocorticoid-mediated repression of nuclear factor-kappaB-dependent transcription involves direct interference with transactivation
2
PubMed Central. Genomic and non-genomic effects of glucocorticoids: implications for breast cancer
3
The American Journal of Medicine. Potency and duration of action of glucocorticoids: Effects of hydrocortisone, prednisone and dexamethasone on human pituitary-adrenal function
4
PubMed Central. Pharmacokinetics of Dexamethasone in Children and Adolescents with Obesity
5
PubMed. Glucocorticoid-induced granulocytosis: contribution of marrow release and demargination of intravascular granulocytes
6
PubMed Central. The differential effect of dexamethasone on granulocyte apoptosis involves stabilization of Mcl-1L in neutrophils but not in eosinophils
7
PubMed. Dexamethasone in Hospitalized Patients with Covid-19
8
PubMed. The story of dexamethasone and how it became one of the most widely used drugs in neurosurgery
9
PubMed Central. Glucocorticoids in the management of peritumoral brain edema: a review of molecular mechanisms
10
PubMed Central. Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth
11
PubMed Central. Rotation from Dexamethasone to Methylprednisolone to Prevent Dexamethasone‐Induced Hiccup in Cancer Patients Treated with Chemotherapy
12
PubMed. A very high dose dexamethasone suppression test for differential diagnosis of Cushing’s syndrome
13
PubMed Central. Anatomical and functional recurrence after dexamethasone intravitreal implants: a 6-month prospective study
14
PubMed. Dexamethasone for the prevention of acute mountain sickness: systematic review and meta-analysis
15
PubMed Central. Steroid-Induced Sleep Disturbance and Delirium: A Focused Review for Critically Ill Patients
16
American Journal of Physiology-Cell Physiology. Expression of glucocorticoid receptor alpha- and beta-isoforms in human cells and tissues
17
Portland Press / Biochemical Journal. Inhibition of human cytosolic phospholipase A2 by human annexin V